Last updated: 2025-11-03 20:38:37 ET
'Create a global health and wellness leader'
Manufacturing giant Kimberly-Clark is set to acquire Kenvue, the maker of Tylenol, for $48.7 billion. CBS News MoneyWatch correspondent Kelly O'Grady ...
The deal will unite two giants in the over-the-counter health business, bringing together brands like Kleenex and Benadryl.
One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common painkiller to autism, which the company is fighting.
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark’s stock tumbled.
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company.
